Review of once-monthly oral ibandronate and the use thereof

  • T De Villiers
  • M Davey
  • B Cassim
  • W De Lange
Keywords: ibandronate, oral, use, once-monthly

Abstract

An advisory board meeting of key opinion leaders was held in 2015 to discuss the clinical data on oral ibandronate in the treatment of postmenopausal osteoporosis. Boniva 150 mg (ibandronate) oral once-monthly is indicated for the treatment of osteoporosis in postmenopausal women, in order to reduce the risk of vertebral fractures.1

Author Biographies

T De Villiers
Chairman Ibandronate Oral Advisory Group
M Davey
Ibandronate Oral Advisory Group
B Cassim
Ibandronate Oral Advisory Group
W De Lange
Ibandronate Oral Advisory Group
Published
2017-05-05
Section
Consensus Document